Clinical characteristics and treatment strategy of nocardiosis in lung transplant recipients: A single-center experience
- PMID: 37092136
- PMCID: PMC10119885
- DOI: 10.1016/j.idcr.2023.e01758
Clinical characteristics and treatment strategy of nocardiosis in lung transplant recipients: A single-center experience
Abstract
Objective: Nocardia are infrequent pathogens that disproportionately afflict organ transplant recipients. The present study aimed to summarize the clinical manifestations, diagnostic approaches, and treatment strategies of nocardiosis in lung transplant recipients.
Methods: This retrospective study reviewed the clinical data of adult lung transplant recipients who were complicated with nocardiosis between January 2018 and December 2021 at the largest lung transplant center in South China.
Results: The incidence of nocardiosis was 4.2% (13/316), including 9 cases of pulmonary nocardiosis and 4 disseminated nocardiosis (blood, pulmonary and intracranial). The accuracy in diagnosing nocardiosis was 77.8% by culture and 100% by metagenomic next-generation sequencing (mNGS). Nocardia farcinica was the most common causative pathogen. Trimethoprim-sulfamethoxazole-based combination therapy was administered initially, followed by a single antibiotic as the maintained therapy, lasting for 4-8 months.
Conclusions: mNGS is more accurate than culture in diagnosing nocardiosis. Most patients responded well to the antibiotic therapy with combined antibiotics at the initial stage followed by a single antibiotic treatment.
Keywords: Infection; Lung transplantation; Metagenomic next-generation sequencing.
© 2023 The Authors.
Conflict of interest statement
The authors declare that the research was conducted in absence of any commercial or financial relationships that may constitute a potential conflict of interest.
Figures


Similar articles
-
Nocardia prophylaxis, treatment, and outcomes of infection in lung transplant recipients: A matched case-control study.Transpl Infect Dis. 2021 Apr;23(2):e13478. doi: 10.1111/tid.13478. Epub 2020 Oct 13. Transpl Infect Dis. 2021. PMID: 32989873
-
Central nervous system nocardiosis diagnosed by metagenomic next-generation sequencing: A case series and literature review.Adv Clin Exp Med. 2023 Dec;32(12):1453-1463. doi: 10.17219/acem/175818. Adv Clin Exp Med. 2023. PMID: 38112280 Review.
-
Nocardia infection in lung transplant recipients.J Heart Lung Transplant. 2002 Mar;21(3):354-9. doi: 10.1016/s1053-2498(01)00394-1. J Heart Lung Transplant. 2002. PMID: 11897524
-
Risk factors and prophylaxis for nocardiosis in solid organ transplant recipients: A nested case-control study.Clin Transplant. 2023 Sep;37(9):e15016. doi: 10.1111/ctr.15016. Epub 2023 May 11. Clin Transplant. 2023. PMID: 37170686
-
Nocardia infections in solid organ and hematopoietic stem cell transplant recipients.Curr Opin Infect Dis. 2017 Dec;30(6):545-551. doi: 10.1097/QCO.0000000000000404. Curr Opin Infect Dis. 2017. PMID: 28922286 Review.
Cited by
-
Clinical Features of Pulmonary Nocardiosis and Diagnostic Value of Metagenomic Next-Generation Sequencing: A Retrospective Study.Pathogens. 2025 Jul 2;14(7):656. doi: 10.3390/pathogens14070656. Pathogens. 2025. PMID: 40732703 Free PMC article.
-
Nocardia farcinica infection presenting as a solitary bronchial neoplasm in an immunocompetent adult: a case report.Front Med (Lausanne). 2024 Jan 10;10:1337303. doi: 10.3389/fmed.2023.1337303. eCollection 2023. Front Med (Lausanne). 2024. PMID: 38274454 Free PMC article.
References
-
- Lerner P.I. Nocardiosis. Clin Infect Dis Publ Infect Dis Soc Am. 1996;22:891–903. - PubMed
-
- Restrepo A., Clark N.M. Nocardia infections in solid organ transplantation: Guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation. Clin Transplant. 2019;33 - PubMed
LinkOut - more resources
Full Text Sources